Data as of Apr 17
| +0.10 / +4.24%|
The 3 analysts offering 12-month price forecasts for InspireMD Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +143.90% increase from the last price of 2.46.
The current consensus among 3 polled investment analysts is to Buy stock in InspireMD Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.